Last reviewed · How we verify
NCT03091413
Correlation Between Pi Max and Diaphragm Maximum Inspiratory Excursion Detected With Ultrasound During Weaning
trial testing diaphragm ultrasound in Weaning. Withdrawn.
1 April 2024
Quick facts
| Lead sponsor | Corporacion Parc Tauli |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 4 April 2022 |
| Primary completion | 1 April 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- diaphragm ultrasound
Conditions studied
- Weaning — all drugs for Weaning →
- Diaphragm Ultrasound — all drugs for Diaphragm Ultrasound →
- Maximum Inspiratory Pressure — all drugs for Maximum Inspiratory Pressure →
Sponsor
Corporacion Parc Tauli — full company profile →
Who can join
18 and older, any sex, with Weaning or Diaphragm Ultrasound. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the correlation between maximum inspiratory pressure (Pi max) and the diaphragm maximum inspiratory excursion measured with ultrasound during the weaning from invasive mechanical ventilation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03091413
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of diaphragm ultrasound
Trials testing the same drug.
- NCT06967623 — Comparison of Weaning Parameters and Diaphragm Thickness Changes · completed
- NCT04424277 — Deformation of the Diaphragm Zone of Apposition · completed
Other recruiting trials for Weaning
Currently open trials in the same condition.
- NCT06561295 — Optimal Timing for Spontaneous Breathing Trials · NA · recruiting
- NCT05719194 — Effect of a Personalized Weaning Strategy on Weaning Success · NA · recruiting
- NCT06839846 — Survey of Different Modes of Weaning in Pediatric Population · recruiting
Other Corporacion Parc Tauli trials
Trials by the same sponsor.
- NCT07331805 — Conservative Management in Primary Spontaneous Pneumothorax: a Multicenter Randomized Non-inferiority Study · NA · not yet recruiting
- NCT06873360 — Medical Device for Oxaliplatin-Induced Neuropathy in Gastrointestinal Cancer Patients · completed
- NCT06900335 — Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact · completed
- NCT06511700 — Implementation of the Intravitreal Injection Administered by Nurses · enrolling by invitation
- NCT07298720 — Assessing Fluid-responsiveness Using Non-invasive Hybrid Diffuse Optics on Peripheral Muscle · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03091413 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Corporacion Parc Tauli
- Last refreshed: 7 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03091413.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing